Behavioural Intervention

Cigarette for Chronic Obstructive Pulmonary Disease

US25; Accel Research Sites, Largo, FL
Targeting 3 different conditionsTHS use +2 moreN/ARecruitingResearch Sponsored by Philip Morris Products S.A.

Study Summary

This trial studies if switching from cigarettes to a Tobacco Heating System can slow COPD symptom progression and improve symptoms in smokers with mild-moderate COPD.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease
  • Tobacco Use
  • Smoking

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Exclusion Criteria

You will be eligible for the trial if you check “No” for criteria below:


Screening ~ 1 day
Treatment ~ 6 months
Follow Up ~3 months
This trial's timeline: 1 day for screening, 6 months for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COPD symptoms
Disease Progression

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: CigaretteActive Control1 Intervention
Subjects who are not willing to quit smoking.
Group II: THSActive Control1 Intervention
Subjects who are not willing to quit smoking.
Group III: Smoking AbstinenceActive Control1 Intervention
Subjects who are willing to quit smoking.

Find a site


Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

Philip Morris Products S.A.Lead Sponsor
45 Previous Clinical Trials
33,716 Total Patients Enrolled
Christelle Haziza, PhDStudy Chair
Philip Morris Products S.A.
26 Previous Clinical Trials
5,535 Total Patients Enrolled

Media Library

Smoking Abstinence (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05569005 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Cigarette, THS, Smoking Abstinence
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Smoking Abstinence Highlights & Side Effects. Trial Name: NCT05569005 — N/A
Smoking Abstinence (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05569005 — N/A
Chronic Obstructive Pulmonary Disease Patient Testimony for trial: Trial Name: NCT05569005 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial allow for participants under 45 years of age?

"This trial is limited to patients aged 40-65 years old. However, individuals outside of this age range can access 38 studies for those under 18 and 425 trials for seniors beyond the age of 65."

Answered by AI

Are there a plethora of Canadian medical facilities conducting this research endeavor?

"Presently, 65 medical sites across Clearwater, Lakeland and Largo are recruiting for this research project. It would be beneficial to choose the clinic nearest you in order to reduce your travel burden if you become a trial participant."

Answered by AI

What is the aggregate number of participants in this trial?

"Confirmed. According to the information displayed on, this study is actively looking for participants and was initially posted December 16th 2022. The trial will include 1895 individuals being recruited from 65 different medical sites."

Answered by AI

Is enrollment open presently for this experiment?

"Affirmative. corroborates that the research is actively searching for 1895 participants to be recruited from 65 different medical facilities. This initiative was initially posted on December 16th 2022 and most recently updated Jun 20th 2023."

Answered by AI

What criteria must be fulfilled in order to qualify for participation in this experiment?

"In order to be included in the trial, individuals must have chronic obstructive pulmonary disease and should lie within a 40-65 age range. Altogether, 1895 patients are desired for this research."

Answered by AI

Who else is applying?

What state do they live in?
What site did they apply to?
US43; San Marcus Research Clinic Inc
US73; Victorium Clinical Research
US53; Alpha Research Institute, LLC
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

I wish to recover my breath if possible. I have been smoking for over 25 years. I’ll try anything. To stop.
~1263 spots leftby Sep 2025